Molnupiravir represents a notable development in the persistent fight against Coronavirus. This oral agent works by introducing errors into the virus's genetic machinery, effectively halting its ability to replicate. While preliminary clinical studies showed encouraging results in reducing the likelihood of hospitalization and death in high-risk pe

Linaclotide, typically prescribed for persistent idiopathic constipation and irritable bowel syndrome with constipation (IBS-C), represents a unique approach to gastrointestinal function. This GC-C agonist works directly within the intestines to increase fluid secretion and expedite bowel movements. Unlike traditional laxatives that primarily act o